Preclinical tests showed that compared with intramuscular vaccine delivery, the needle-free method resulted in higher antibody levels against H1N1 flu antigen.

Transplanted mouse and human organoids showed kidney-like functions like blood filtration, protein uptake, and urine production.

Biologics developers are caught in a paradox: demand for therapies is climbing, but the industry faces constant pressure to cut costs and move faster.

Academic, industry, and FDA collaboration is key to personalized treatment manufacturing, says Aldevron’s Max Sellman at BPI this week.

The purification and separation of the product of interest from process- and product-related impurities remains a major challenge in development.

Antibody purification evolves with diverse formats, driving tailored chromatography solutions for efficiency, scalability, and sustainability.

AI-guided design of 16 functional bacteriophage genomes offers a path for phage-based therapies against antibiotic-resistant infections.

The findings could help explain why for many individuals with Crohn’s disease patients, anti-inflammatories aren’t sufficient to stop the disease.

Elli Lilly has chosen a location near Richmond, VA, for its planned $5 billion manufacturing plant that will be the first-ever dedicated, fully integrated active pharmaceutical ingredient (API) and ...

Flexynesis uses deep learning to evaluate multi-omics data as well as specially processed texts and images, including CT or ...

A CRISPR mouth-swab test could transform TB screening with rapid, low-cost detection in low-resource and asymptomatic cases.

Traditional microbial expression systems can be advanced through improved plasmid replication, target gene transcription, ...